GPRE Green Plains Inc.
Industrial Organic Chemicals · Nasdaq · SEC CIK 1309402 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-19.1%
TTM net income YoY204.9%
TTM EPS YoY186.3%
Revenue 3-yr CAGR-19.6%
Net income 3-yr CAGR—
Margins
Gross margin21.1%
Operating margin10.7%
Net margin10.9%
FCF margin4.4%
EBITDA margin15.9%
Returns
ROE22.9%
ROA12.1%
ROIC (approx.)18.4%
Asset turnover1.11x
Leverage & solvency
Liabilities / assets44.7%
Debt / equity0.48x
Current ratio2.31x
Interest coverage5.76x
Cash quality & payout
Operating cash flow / net income0.58x
Accruals ratio5.1%
Payout ratio—
Capex / revenue1.9%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $2.09B | $2.46B | $3.30B | $3.66B | $2.83B |
| Cost of revenue | $1.95B | $2.33B | $3.13B | $3.55B | $2.63B |
| Gross profit | $136.93M | $130.45M | $164.75M | $112.68M | $202.06M |
| SG&A expense | $122.71M | $118.05M | $133.35M | $118.93M | $91.14M |
| Operating income | -$67.25M | -$47.46M | -$61.58M | -$98.95M | $25.51M |
| Interest expense | $76.67M | $33.09M | $37.70M | $32.64M | $67.14M |
| Pretax income | -$143.82M | -$71.30M | -$82.35M | -$98.70M | -$43.00M |
| Income tax | -$51.75M | $6.21M | -$5.62M | $4.75M | $1.84M |
| Net income | -$121.28M | -$82.50M | -$93.38M | -$127.22M | -$65.99M |
| EBITDA | $31.19M | $43.13M | $36.67M | -$6.25M | $117.46M |
| EPS (basic) | -1.80 | -1.29 | -1.59 | -2.29 | -1.41 |
| EPS (diluted) | -1.80 | -1.29 | -1.59 | -2.29 | -1.41 |
| Weighted avg. shares (diluted) | 67.50M | 63.80M | 58.81M | 55.54M | 46.65M |
| Balance sheet | |||||
| Cash & equivalents | $182.32M | $209.40M | $378.76M | $500.28M | $560.96M |
| Short-term investments | — | — | — | $0 | $124.86M |
| Receivables | $74.37M | $94.90M | $94.45M | $108.61M | $119.96M |
| Current assets | $522.54M | $569.03M | $732.73M | $928.75M | $1.12B |
| PP&E, net | $957.26M | $1.04B | $1.02B | $1.03B | $893.52M |
| Goodwill | — | — | — | $29.13M | $29.13M |
| Intangibles | $10.48M | $12.67M | $15.14M | $17.99M | $22.75M |
| Total assets | $1.58B | $1.78B | $1.94B | $2.12B | $2.16B |
| Current liabilities | $268.71M | $385.69M | $384.96M | $486.92M | $471.80M |
| Short-term debt | $3.92M | $2.12M | $1.83M | $1.84M | $35.28M |
| Long-term debt | $361.99M | $432.46M | $491.92M | $495.24M | $514.01M |
| Total debt | $365.92M | $434.58M | $493.75M | $497.08M | $549.29M |
| Total liabilities | $812.92M | $907.64M | $949.27M | $1.06B | $1.06B |
| Shareholders' equity | $766.25M | $865.22M | $843.73M | $910.03M | $950.50M |
| Net debt | $183.60M | $225.18M | $114.99M | -$3.19M | -$11.67M |
| Shares outstanding | 69.83M | 64.71M | 59.52M | 59.30M | 53.60M |
| Cash flow statement | |||||
| Operating cash flow | $110.86M | -$29.96M | $56.35M | $69.71M | $4.25M |
| Capital expenditure | $37.20M | $95.08M | $108.09M | $212.37M | $187.19M |
| Free cash flow | $73.67M | -$125.05M | -$51.75M | -$142.66M | -$182.95M |
| Investing cash flow | $162.13M | -$62.05M | -$106.90M | -$105.25M | -$236.28M |
| Financing cash flow | -$252.26M | -$77.35M | -$70.96M | -$25.14M | $518.19M |
| Depreciation & amortization | $98.43M | $90.59M | $98.24M | $92.70M | $91.95M |
| Stock-based compensation | $17.12M | $8.27M | $13.03M | $9.07M | $6.06M |
| Dividends paid | $721,000 | $5.17M | $22.73M | $22.55M | $9.25M |
| Share buybacks | $30.00M | $0 | $0 | $0 | $0 |
Free plan shows the latest 5 periods; Pro shows all 17 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.